Concepedia

Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck

Patricia A. Tang, Lillian L. Siu, Eric X. Chen, Sébastien J. Hotte, Stephen Chia, James K. Schwarz, Gregory R. Pond, Caitlin Johnson, A. Dimitrios Colevas, Timothy W. Synold,

Investigational New Drugs · 2007 · 81 citations · 15 references

DOI

Concepts

References

15

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +12

Optimal two-stage designs for phase II clinical trials

Richard Simon · Controlled Clinical Trials · 1989 · 3.6K citations

, , +10

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.

Arlene A. Forastiere, Barbara Metch, Dorit Elisabeth Schuller et al. · Journal of Clinical Oncology · 1992 · 753 citations

, , +13

A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck.

Charlotte Jacobs, Gary H. Lyman, E Vélez-García et al. · Journal of Clinical Oncology · 1992 · 633 citations

, , +11

Randomized Phase III Evaluation of Cisplatin Plus Fluorouracil Versus Cisplatin Plus Paclitaxel in Advanced Head and Neck Cancer (E1395): An Intergroup Trial of the Eastern Cooperative Oncology Group

Michael K. Gibson, Yi Li, Barbara A. Murphy et al. · Journal of Clinical Oncology · 2005 · 494 citations

, , +14